The NHMRC-National Institute for Health Research Collaborative Research Grants scheme supports Australian participation and collaboration in leading international collaborative research through the United Kingdom’s NIHR Health Technology Assessment (HTA) Programme. The HTA Programme funds independent research about the effectiveness, costs and broader impact of healthcare treatments and tests.
The NIHR HTA Programme invites applications in response to calls for research on specific topics. Funding is for up to five years. NHMRC is providing up to $3 million to support the Australian components of successful projects over three rounds. Round 2 will address the following research topics:
- 20/72 Oxybutynin for the treatment of vasomotor symptoms associated with menopause
- 20/73 Surgery for endometrioma in women undergoing IVF
- 20/74 Antidepressants for post-stroke emotionalism
- 20/75 Conservative management of primary spontaneous pneumothorax
- 20/76 Reverse vs conventional shoulder replacement for adults with osteoarthritis
- 20/77 Treatment of recurrent patella dislocation
- 20/96 Partial vs total nephrectomy for clinically localised renal cell carcinoma.
Further information on the NIHR HTA commissioned research topics is available on the NIHR website.
- NIHR invites Stage 1 submissions against advertised research topics
- NIHR and NHMRC invite successful Stage 1 applicants to submit a Stage 2 application. Australian-based researchers are invited to apply to NHMRC for support of the Australian components of the research by submitting an application in Sapphire
- NIHR conducts peer review of all Stage 2 applications submitted
- NIHR advises NHMRC of Stage 2 applications deemed fundable by the NIHR
- NHMRC conducts eligibility checks for the eligible Australian collaborations
- NHMRC reviews the budget requested for the Australian components of eligible collaborations
- Funding recommendations approval process.
The NHMRC-NIHR scheme has eligibility criteria and applications will be excluded from consideration if eligibility requirements are not met:
- The Chief Investigator A (CIA) and their Administering Institution must be named as the Australian Partner Investigator on an application submitted to the NIHR
- The application must have been shortlisted based on scientific peer review by NIHR in order to be considered for funding by NHMRC
- Other Australian researchers listed on the NIHR application must be identified as CIs in the application to NHMRC
- Australian applicants must provide the Australian budget details on the NHMRC-NIHR Scheme application form (in Sapphire).
The Australian applicants must be successful through the NIHR HTA process to be eligible to receive funding from NHMRC.